We want to start with complete transparency: definitive endometrial (uterine) cancer treatment — surgical staging, radiation, and chemotherapy — is delivered by a gynaecologic oncologist, working within a specialised cancer care team. This is the internationally recognised standard of care, reflected in guidelines from bodies including the National Comprehensive Cancer Network (NCCN) and the European Society of Gynaecological Oncology (ESGO).
What this article offers is an accurate, evidence-based overview of how endometrial cancer is treated — so you understand your options and questions to ask — along with a clear explanation of where general gynaecology and fertility medicine genuinely contribute to your care.
The Standard Treatment Approach
According to current international treatment guidelines, the standard first-line treatment for endometrial cancer is:
Total hysterectomy with bilateral salpingo-oophorectomy (TH/BSO), combined with surgical staging, which typically includes assessment of the pelvic and para-aortic lymph nodes.
Surgical Approach Options
This surgery can be performed through several approaches:
- Abdominal (open) surgery
- Laparoscopic surgery
- Robotic-assisted surgery
- Vaginal surgery, in select cases
Research comparing these approaches has found robotic hysterectomy may offer advantages in some outcomes — including reduced complications, shorter hospital stay, and less blood loss — compared with open or standard laparoscopic surgery, according to recent meta-analyses, though the right approach depends on individual staging and surgical factors determined by your gynaecologic oncology team.
Additional (Adjuvant) Treatment
Depending on your specific stage and pathology findings after surgery, additional treatment may be recommended:
- Radiation therapy — including external beam radiation therapy (EBRT) and/or brachytherapy (internal radiation)
- Chemotherapy — generally for higher-stage or higher-risk disease
- Hormone therapy — sometimes considered for select patients, particularly those with lower-grade disease who aren’t candidates for immediate surgery
Current protocols determine adjuvant treatment based on your specific FIGO stage, tumour grade, and — increasingly — molecular subtype, following the 2023 update to international staging guidelines.
Fertility-Sparing Treatment: An Important, Highly Selective Option
For a small subset of young patients — generally those with grade 1 (sometimes grade 2), stage IA (non-invasive) endometrioid endometrial cancer who strongly wish to preserve fertility — fertility-sparing treatment may be considered as an alternative to immediate hysterectomy.
It’s important to understand: this is genuinely not the standard of care. It’s reserved for carefully selected patients, requires thorough counselling about the risks involved, and demands close, ongoing oncological surveillance throughout treatment.
Fertility-Sparing Treatment Options
- Oral progestins (such as medroxyprogesterone acetate or megestrol acetate)
- Levonorgestrel-releasing intrauterine device (LNG-IUD), sometimes combined with systemic progestins
- GnRH agonists, in some protocols
- Hysteroscopic resection followed by progestin therapy — one specific approach shown in research to achieve a high complete response rate, though with a meaningful recurrence rate that requires careful, ongoing monitoring
A comprehensive review of 18 studies covering nearly 24,000 patients found complete response rates ranging widely (18–100%) and recurrence rates also varying significantly (0–81.8%) depending on the specific protocol and patient selection — underscoring how individualised and closely monitored this approach needs to be.
A critical point: even among patients pursuing fertility-sparing treatment, the decision about when — or whether — to eventually proceed with definitive surgery once childbearing is complete remains a carefully individualised oncological decision, made in ongoing consultation with a gynaecologic oncology team.
How Diagnosis Leads to Treatment Planning
- Endometrial biopsy confirms the histological diagnosis
- Imaging (transvaginal ultrasound, and often MRI) helps assess the extent of disease before surgery
- Definitive staging, however, can only be confirmed after surgery itself
- Molecular/genomic classification, now incorporated into 2023 FIGO staging, increasingly informs both prognosis and treatment planning
Where General Gynaecology and Fertility Medicine Fit Into Your Care
We want to be precise about this, since it matters for your safety and your outcome:
What requires a gynaecologic oncologist: Diagnosis confirmation and staging surgery, radiation therapy, chemotherapy, and ongoing oncological surveillance — including for patients pursuing fertility-sparing treatment.
Where general gynaecology and fertility medicine contribute:
- Recognising abnormal uterine bleeding — the most common early symptom — and pursuing prompt initial evaluation
- Initial diagnostic imaging and endometrial biopsy
- Coordinating referral to an appropriate gynaecologic oncology team without delay
- Supporting fertility preservation conversations for young patients, working alongside — not instead of — the treating oncology team
Endometrial Health Evaluation at Sree Swapna Fertility Centre
As one of the best fertility centers in Hyderabad, we take abnormal uterine bleeding seriously as a symptom warranting prompt evaluation, particularly given how meaningfully early detection affects endometrial cancer outcomes.
Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, with over 15 years of experience in gynaecology. Both our Kondapur and Attapur clinics offer in-house transvaginal ultrasound and endometrial biopsy for initial evaluation, with prompt, coordinated referral to gynaecologic oncology whenever findings raise concern — and ongoing fertility preservation support for younger patients navigating this diagnosis alongside their oncology care.
Frequently Asked Questions
1. What is the standard treatment for endometrial cancer?
The standard first-line treatment is total hysterectomy with bilateral salpingo-oophorectomy and surgical staging, performed by a gynaecologic oncologist.
2. Does Sree Swapna Fertility Centre perform endometrial cancer surgery?
No, staging surgery, radiation, and chemotherapy require a gynaecologic oncology team. We provide initial evaluation and coordinate referral for definitive treatment.
3. Is fertility-sparing treatment an option for everyone with endometrial cancer?
No, it’s reserved for a carefully selected group of young patients with early-stage, low-grade disease who strongly wish to preserve fertility, and is not the standard of care.
4. What does fertility-sparing treatment for endometrial cancer involve?
Options include oral progestins, an LNG-IUD, sometimes combined with hysteroscopic resection, all under close, ongoing oncological monitoring.
5. How effective is fertility-sparing treatment?
Research shows widely varying complete response and recurrence rates depending on the specific protocol, which is why individualised, closely monitored care is essential.
6. Is robotic surgery better than open surgery for endometrial cancer?
Some research suggests robotic hysterectomy may offer advantages like fewer complications and shorter hospital stay, though the right approach depends on individual factors determined by your surgical team.
7. What is surgical staging in endometrial cancer treatment?
It involves assessing pelvic and para-aortic lymph nodes during surgery to determine how far the cancer has spread, guiding further treatment decisions.
8. When is radiation therapy used for endometrial cancer?
It’s typically used as adjuvant treatment based on stage and risk factors, or as primary treatment for patients who aren’t surgical candidates.
9. When is chemotherapy recommended?
Generally for higher-stage or higher-risk endometrial cancer, as determined by your treating oncology team.
10. What is the most common early symptom of endometrial cancer?
Abnormal uterine bleeding, particularly bleeding after menopause, is the most common early warning sign.
11. Can ovaries be preserved during endometrial cancer surgery?
In select premenopausal patients with low-grade, stage IA disease, ovarian preservation may be considered, though it’s not recommended for those with genetic risk factors like BRCA mutations or Lynch syndrome.
12. What is the 2023 FIGO staging update?
It incorporated molecular/genomic classification alongside traditional anatomical staging, improving prognosis prediction accuracy.
13. Can definitive diagnosis be made before surgery?
Imaging and biopsy can strongly suggest the diagnosis and stage, but definitive staging is generally confirmed only after surgery.
14. Is fertility-sparing treatment guaranteed to work?
No, response and recurrence rates vary significantly across studies, and it requires strict counselling and close, ongoing monitoring.
15. What happens after fertility-sparing treatment is complete?
The decision about proceeding with definitive surgery afterward is individualised and made in ongoing consultation with your gynaecologic oncology team.
16. Should every case of abnormal bleeding be evaluated for endometrial cancer?
Any abnormal or postmenopausal bleeding should be evaluated by a doctor, though most cases have benign causes.
17. Can general gynaecology help coordinate care during endometrial cancer treatment?
Yes, particularly around initial evaluation and fertility preservation support, working alongside your oncology team.
18. What imaging is used before endometrial cancer surgery?
Transvaginal ultrasound and often MRI are used to assess disease extent before surgical planning.
19. Is genetic testing relevant to endometrial cancer treatment decisions?
Yes, particularly for decisions like ovarian preservation, where genetic risk factors such as Lynch syndrome are an important consideration.
20. Can younger women get endometrial cancer?
Yes, though less common than in postmenopausal women, which is exactly why fertility-sparing treatment options have become an important area of research.
21. How is a gynaecologic oncologist different from a general gynaecologist?
A gynaecologic oncologist has specialised training in cancer staging, surgery, and coordinated oncological treatment, beyond general gynaecological practice.
22. Where can I get initial evaluation for abnormal bleeding in Hyderabad?
Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers transvaginal ultrasound and endometrial biopsy at both our Kondapur and Attapur clinics, with prompt oncology referral when needed.
Conclusion
Endometrial cancer treatment follows well-established, internationally recognised protocols — primarily surgical staging, with radiation and chemotherapy added based on individual risk factors, and select fertility-sparing options for carefully chosen younger patients. Getting to a qualified gynaecologic oncology team promptly, following early symptom recognition, remains one of the most important factors in a good outcome.
Concerned About Abnormal Bleeding or Need Fertility Preservation Support?
Dr. Swapna Naik and the team at Sree Swapna Fertility Centre can provide prompt evaluation and coordinate specialist oncology care alongside fertility preservation support.
📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us
